Single-cell RNA sequencing reveals spatiotemporal heterogeneity and malignant progression in pancreatic neuroendocrine tumor.
Zhou Y, Liu S, Liu C, Yang J, Lin Q, Zheng S, Chen C, Zhou Q, Chen R.
Int J Biol Sci. 2021 Aug 28;17(14):3760-3775. doi: 10.7150/ijbs.61717. eCollection 2021.
[Recurrent laryngeal papillomatosis].
Coordes A, Grund D, Mainka A, Olze H, Hanitsch L, von Bernuth H, Dommerich S.
HNO. 2023 Feb;71(2):77-82. doi: 10.1007/s00106-022-01250-1. Epub 2022 Dec 7.
Malignant pericardial effusion.
Burazor I, Imazio M, Markel G, Adler Y.
Cardiology. 2013;124(4):224-32. doi: 10.1159/000348559. Epub 2013 Apr 5.
[Pheochromocytoma: pediatric features].
Dubois R, Chappuis JP.
Arch Pediatr. 1997 Dec;4(12):1217-25. doi: 10.1016/s0929-693x(97)82613-9.
Trousseau's syndrome.
Callander N, Rapaport SI.
West J Med. 1993 Apr;158(4):364-71.
Presence of a Malignant Tumor as a Novel Predictive Factor for Repeated Recurrences of Chronic Subdural Hematoma.
Hori YS, Aoi M, Oda K, Fukuhara T.
World Neurosurg. 2017 Sep;105:714-719. doi: 10.1016/j.wneu.2017.06.043. Epub 2017 Jun 20.
Tumor recurrence and hypertension persistence after successful pheochromocytoma operation.
Plouin PF, Chatellier G, Fofol I, Corvol P.
Hypertension. 1997 May;29(5):1133-9. doi: 10.1161/01.hyp.29.5.1133.
Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancer.
Karamitopoulou E, Wenning AS, Acharjee A, Zlobec I, Aeschbacher P, Perren A, Gloor B.
Gut. 2023 Aug;72(8):1523-1533. doi: 10.1136/gutjnl-2022-329371. Epub 2023 Feb 15.
Dexamethasone reduces tumor recurrence and metastasis after pancreatic tumor resection in SCID mice.
Egberts JH, Schniewind B, Pätzold M, Kettler B, Tepel J, Kalthoff H, Trauzold A.
Cancer Biol Ther. 2008 Jul;7(7):1044-50. doi: 10.4161/cbt.7.7.6099. Epub 2008 Apr 14.
Outcome after bilateral deep vein thrombosis.
Fürbringer-Schwarz A, Janscak M, Jeanneret-Gris CR.
Vasa. 2022 Nov;51(6):372-376. doi: 10.1024/0301-1526/a001030. Epub 2022 Sep 23.
